SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data fromCaPSURE). J Urol 2003; 170: S215
  • 2
    D’Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 96974
  • 3
    Kane CJ, Presti JC, Amling CL, Aronson WJ, Terris MK, Freedland SJ. Changing nature of high risk patients undergoing radical prostatectomy. J Urol 2007; 177: 1137
  • 4
    Perrotti M, Rabbani F, Russo P, Solomon MC, Fair WR. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. Urology 1998; 52: 10610
  • 5
    Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 2002; 168: 5259
  • 6
    Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095101
  • 7
    Freedland SJ, Humphreys EB, Mangold LA et al. Risk of prostate cancer- specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 4339
  • 8
    Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. Treatment of patients with high risk localized prostate cancer: results form cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol 2005; 173: 155761
  • 9
    Do TM, Parker RG, Smith RB, Kagan AR. High-grade carcinoma of the prostate: a comparison of current local therapies. Urology 2001; 57: 11217
  • 10
    Rioux-Leclercq NC, Chan DY, Epstein JI. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 810 adenocarcinoma. Urology 2002; 60: 6669
  • 11
    Mian BM, Troncoso P, Okihara K et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 2002; 167: 167580
  • 12
    Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8. BJU Int 2003; 92: 53944
  • 13
    Sciarra A, Gentile V, Voria G et al. Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8–10. Urol Int 2003; 70: 18694
  • 14
    Hurwitz MD, Schultz D, Richie JP et al. Radical prostatectomy for high-grade prostate cancer. Urology 2006; 68: 36770
  • 15
    Lau WK, Bergstralh EK, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer. influence of concomitant pathological variables. J Urol 2002; 167: 11722
  • 16
    Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003; 169: 15763
  • 17
    Aihara M, Lebovitz RM, Wheeler TM, Kinner BM, Ohori M, Scardino PT. Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer. J Urol 1994; 151: 155864
  • 18
    Hanks GE, Pajak TF, Porter A et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the radiation therapy oncology group protocol 92–02. J Clin Oncol 2003; 21: 39728
  • 19
    Konety BR, Eastham JA, Reuter VE et al. Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. J Urol 2004; 171: 70913
  • 20
    Seay TM, Blute ML, Zincke H. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation. J Urol 1998; 159: 35764